SCHEMBL6743148

SCHEMBL6743148

NS(=O)(=O)c1c(F)cc(-c2ncccc2-c2ccccc2)cc1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 5/20 0.51
PTGS1 P23219 4/20 0.51
FEN1 P39748 6/20 0.48
CA1 P00915 2/20 0.43
CA2 P00918 2/20 0.43
ALOX5AP P20292 3/20 0.40
ALDH1A1 P00352 1/20 0.39
HTT P42858 1/20 0.39
HSD17B10 Q99714 1/20 0.39
TOP1 P11387 1/20 0.39
CTSL P07711 1/20 0.38
PTPRC P08575 1/20 0.38
CTSS P25774 1/20 0.38
PTPN13 Q12923 1/20 0.38
TDP2 O95551 1/20 0.38
NSD2 O96028 1/20 0.38
ABL1 P00519 1/20 0.38
PLCG1 P19174 1/20 0.38
CES1 P23141 1/20 0.38
PAX8 Q06710 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6746852 0.90 PTGS2 (0.47) PTGS2PTGS1FEN1CA1CA2
SCHEMBL6746225 0.89 PTGS2 (0.43) PTGS2PTGS1FEN1CA1CA2
SCHEMBL6747444 0.88 PTGS2 (0.44) PTGS2PTGS1FEN1CA1CA2
SCHEMBL6744788 0.88 PTGS2 (0.48) PTGS2PTGS1FEN1CA1CA2
SCHEMBL6744241 0.88 FEN1 (0.43) PTGS2PTGS1FEN1CA1CA2
SCHEMBL6746820 0.88 PTGS2 (0.51) PTGS2PTGS1FEN1CA1CA2
SCHEMBL6744767 0.88 CA1 (0.42) PTGS2PTGS1FEN1CA1CA2
SCHEMBL6746754 0.88 FEN1 (0.44) PTGS2PTGS1FEN1CA1CA2
SCHEMBL6747196 0.86 CA1 (0.43) PTGS2PTGS1FEN1CA1CA2
SCHEMBL6746016 0.86 RORB (0.43) PTGS2PTGS1FEN1CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 US claimed
US-6699884-B2 ANTIINFLAMMATORY CYCLOOXYGENASE INHIBITORS. PHARMACIA CORPORATION 2004-03-02 US disclosed